Beamtree Holdings Ltd
ASX:BMT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.185
0.32
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Beamtree Holdings Ltd
Revenue
Beamtree Holdings Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Beamtree Holdings Ltd
ASX:BMT
|
Revenue
AU$28.6m
|
CAGR 3-Years
20%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Revenue
AU$5.9m
|
CAGR 3-Years
77%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Revenue
$53.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Revenue
AU$220.5m
|
CAGR 3-Years
33%
|
CAGR 5-Years
31%
|
CAGR 10-Years
29%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Revenue
AU$40.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
80%
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Revenue
AU$28k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beamtree Holdings Ltd
Glance View
Beamtree Holdings Ltd. is an Australian healthcare technology company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-06-06. The firm work with health organizations to capture, manage and leverage human skills. The firm enables healthcare providers to access information, automate wherever possible and make informed decisions. Its products and services include picq, RippleDown Expert, RippleDown Auditor, RISQ, Q Coding platform and codexpert. RippleDown Expert automatically applies clinical solutions to generate patient-centric reports. Its Q Coding platform provides an end-to-end workflow suite for clinical coding, grouping, reporting and auditing. RippleDown Auditor automates real-time reviews of all data in pathology. Codexpert is used in clinical coding classification reference. RISQ improves identification and benchmarking better patient care.
See Also
What is Beamtree Holdings Ltd's Revenue?
Revenue
28.6m
AUD
Based on the financial report for Jun 30, 2025, Beamtree Holdings Ltd's Revenue amounts to 28.6m AUD.
What is Beamtree Holdings Ltd's Revenue growth rate?
Revenue CAGR 5Y
47%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Beamtree Holdings Ltd have been 20% over the past three years , 47% over the past five years .